Opinion|Videos|December 23, 2024
Using Technology for Early Detection of LEMS
A panelist discusses how enhanced screening protocols combined with predictive analytics can accelerate Lambert-Eaton myasthenic syndrome (LEMS) detection in high-risk populations like patients with small cell lung cancer (SCLC) while also exploring the potential of telemedicine to improve early diagnosis in underserved communities.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can improved screening protocols and the integration of predictive analytics in clinical practice enhance early detection of LEMS in high-risk patients, such as those with SCLC, and which patient populations should be prioritized?
- In what ways can telemedicine and digital health tools support earlier detection of LEMS, especially in underserved areas?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Novel CLL Therapies Prompt New Treatment Considerations
2
Congress Unveils Massive Funding Bill to Avert Shutdown
3
Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access
4
Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma
5
